Association of HER2/neu single nucleotide polymorphism with trastuzumab-related cardiotoxicity in patients with breast cancer
Phase of Trial: Phase III
Latest Information Update: 17 Nov 2014
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 17 Nov 2014 Title is not official; location and phase is assumed.
- 17 Nov 2014 New trial record
- 01 Mar 2013 Recruitment completed, according to 36th Annual San Antonio Cancer Symposium.